FOXO3 and liver cancer: Regarding liver cancer, several studies sustain that abnormal FOXO3 overexpression could represent an unfavorable hallmark in HCC, being linked to multidrug resistance [13,14], more aggressive phenotypes and a worse long-term prognosis [12,15,16,17].